StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $451 at RBC Capital
November 5, 2024 7:00 AM
RBC Capital analyst Brian Abrahams raised the price target on Vertex (NASDAQ: VRTX) to $451.00 (from $437.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Vertex Pharma (VRTX) Tops Q3 EPS by 30c; raises guidance
November 4, 2024 4:03 PM
Form 8-K VERTEX PHARMACEUTICALS For: Nov 04
November 4, 2024 4:03 PM
Vertex Reports Third Quarter 2024 Financial Results
November 4, 2024 4:01 PM
Vertex Pharma (VRTX) November 11 weekly option implied volatility into quarter results
November 1, 2024 11:02 AM
Vertex Pharma (VRTX) November 11 weekly 475 straddle priced into quarter results
November 1, 2024 5:23 AM